Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. (Q44682228)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. |
scientific article |
Statements
Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study (English)
Ya-Mei Bai
Shun-Chieh Yu
Chao-Cheng Lin
1 November 2003